ClinicalTrials.gg
CompletedNCT03412578Updated Jun 8, 2022

Effect of Tactile/Kinaesthetic Massage Therapy on DXA Parameter of Preterm Infants

An interventional study of Massage Therapy in Preterm Infant, Body Composition and Dual X-ray Absorptiometry (DXA) Scan, sponsored by Mansoura University Children Hospital. Completed at 2 sites in Egypt. Open to participants aged 35 Weeks to 36 Weeks. Per ClinicalTrials.gov, last updated 2022-06-08.

Sponsored by Mansoura University Children Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 3 years 4 months after the study started (first participant enrolled Sep 2014, registered Jan 2018).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
35 Weeks to 36 Weeks
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 12 studies in Premature Birth by Mansoura University Children Hospital — none open to participants now, none under way, none of them phase 3. Premature Birth · Mansoura University Children Hospital.

Enrollment
5th of 12
60 · median 60
Started
2014
the only one that year
No phase
7 of 12
none open now
Registered
5th of 12
by date

Among the 12 studies in Premature Birth by Mansoura University Children Hospital, this one is the 5th largest by enrollment, is the only one that started in 2014, is one of 7 with no phase, and was the 5th registered.

Premature Birth

2,556 studies on the registry are indexed under Premature Birth; 503 are open to participants now.

Browse Premature Birth studies →

Open to participants now

None of the 12 studies in Premature Birth by Mansoura University Children Hospital is open now. The open studies under Premature Birth, anywhere →

Where they have run

Who these studies take

Of the 317 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 225 (71%) stop at 75 or younger; 242 take children under 18; 104 take healthy volunteers.

This study: 35 Weeks to 36 Weeks · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 12 studies in Premature Birth by Mansoura University Children Hospital as a file.
02

Study summary

The effect of Tactile/Kinaesthetic massage therapy on weight gain and different components of growth, as assessed by anthropometric measurements and DXA scan, and correlate these components with serum IGF-1, leptin and adiponectin in preterm infants.

Read the detailed description

Prospective open label randomized, single-blind, controlled trial was done in the NICU at Mansoura University Children's Hospital.

Stable preterm infants in the NICU awaiting for sustained pattern of weight gain were included in the study.

Massage therapy was started at corrected gestational age of 35 weeks and continued for 5 consecutive days. The protocol of massage therapy was performed as been described by Tiffany Field. Three consecutive, 15 minutes, sessions were performed daily after the noon feeding. Each treatment session was divided into 5 minutes of tactile stimulation, followed by 5 minutes of kinaesthetic stimulation, and then another 5 minutes of tactile stimulation.

During massage therapy, infant's behavioural reaction was observed for signs of distress (e.g., yawning, finger splaying, crying). Vital signs are measured 15 minutes before, 15 minutes during and 15 minutes after the massage procedure. If signs of physiologic distress developed (heart rate greater than 200 bpm), massage was discontinued for 15 seconds, or until a return to baseline levels.

The study was discontinued if five periods of observed behavioural or physiological stress occurred.

Body composition assessment using DXA scan was performed for total body All infants were studied on one occasion by the end of 5 days massage therapy. DXA scan was performed without sedation but a pacifier with non-metallic parts was used as needed. The scanning procedure was interrupted if movement artefacts is noted. In addition, analyses of different body regions were also performed. Regional analyses typically involved the head, each of the four extremities, and the trunk.

Blood samples were collected using standard technique at baseline and after 5 days for measurement of IGF-1, leptin and adiponectin levels using Enzyme-linked Immunosorbent Assay [ELISA kit supplied by Elabscience Biotechnology (No.1 Shizishan Street, Wuhan, Hubei, China) catalog No: E-EL-H0086].

Randomization Infants were assigned randomly, by a designated neonatologist, to treatment groups using internet based random table technique with cards in opaque sealed envelopes that were kept in the neonatal care unit. A written informed consent was obtained from the parents of each infant upon enrolment in the study. Procedures of MT, DXA scan, and laboratory analysis were performed by a designated personnel throughout the study to ensure consistency. Performers of DXA scan and laboratory measures were blinded to groups of intervention.

03

Conditions studied

  • Preterm Infant
  • Body Composition
  • Dual X-ray Absorptiometry (DXA) Scan

Browse trials for

04

Who can participate

Ages eligible
35 Weeks to 36 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Medically stable premature infants with gestational age at 28 to 37 weeks' admitted to the "grower" (step-down) nursery. Stability is defined as lack of need for supplemental oxygen, apneas and bradycardias, systemic antimicrobial therapy for infection, or a central line. On at least 100 ml/kg/d of feed (oral or tube feed) preterm formula. will be obtained from parents before enrollment in the study.

Exclusion criteria

Exclusion Criteria:

  • History of necrotizing enterocolitis, receipt of postnatal , active infection, congenital malformations, chromosomal abnormality, intracranial hemorrhage more than (>) grade 2, inborn errors of metabolism, meningitis or encephalopathy, need for surgery.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • No intervention
    Control

    Infants in this group will receive ordinary supportive care and will not receive Massage Therapy

  • Active comparator
    Massage group

    Infants in this group will receive Massage Therapy Massage therapy was started at corrected gestational age of 35 weeks and continued for 5 consecutive days. The protocol of massage therapy was performed as been described by Tiffany Field (Field, Schanberg et al. 1986). Three consecutive, 15 minutes, sessions were performed daily after the noon feeding. Each treatment session was divided into 5 minutes of tactile stimulation, followed by 5 minutes of kinaesthetic stimulation, and then another 5 minutes of tactile stimulation (Field, Diego et al. 2006). During massage therapy, infant's behavioural reaction was observed for signs of distress (e.g., yawning, finger splaying, crying).

    Procedure: Massage Therapy

Interventions

  • ProcedureMassage Therapy

    Massage therapy was started at corrected gestational age of 35 weeks and continued for 5 consecutive days. The protocol of massage therapy was performed as been described by Tiffany Field (Field, Schanberg et al. 1986). Three consecutive, 15 minutes, sessions were performed daily after the noon feeding. Each treatment session was divided into 5 minutes of tactile stimulation, followed by 5 minutes of kinaesthetic stimulation, and then another 5 minutes of tactile stimulation (Field, Diego et al. 2006).

06

What researchers measure

Primary outcomes

  1. Growth parameter (Weight)

    Daily weight gain in grams and cumulative weight gain after 5 days of intervention

    Time frame: 5 days

  2. Growth parameter (Length)

    Daily length gain in cm and cumulative length gain after 5 days of intervention

    Time frame: 5 days

  3. Growth parameter (Head circumference)

    Daily head circumference gain in cm and cumulative head circumference gain after 5 days of intervention

    Time frame: 5 days

  4. Growth parameter (Mid-arm circumference)

    Daily mid-arm circumference gain in cm and cumulative mid-arm circumference gain after 5 days of intervention

    Time frame: 5 days

  5. Growth parameter (Ponderal Index)

    Daily changes in Ponderal Index and cumulative changes in Ponderal Index after 5 days of intervention

    Time frame: 5 days

Secondary outcomes

  1. Dual X-ray absorptiometry scan (DXA scan)

    DXA scan will be performed prior to and 5 days after massage therapy to measure bone mineral density at different levels in the body

    Time frame: 5 days

  2. Insulin-like Growth Factor 1 (IGF-1)

    Serum level of IGF-1 will be measured at baseline and 5 days after massage therapy

    Time frame: 5 days

  3. Serum Leptin

    Serum level of Leptin will be measured at baseline and 5 days after massage therapy

    Time frame: 5 days

  4. Serum adiponectin

    Serum level of adiponectin will be measured at baseline and 5 days after massage therapy

    Time frame: 5 days

07

Study locations

2 sites
  • Mansoura university children hospital
    Mansourah, El Dakahlya 35111, Egypt
  • Mansourah, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2014 to primary completion in Dec 2018, 51 months.

Of 746 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's 51 months is above that.

Counting every sponsor, half of 764 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2018
First posted
Jan 26, 2018
StartActual
Sep 2014
Primary completionActual
Dec 2018
CompletionActual
Dec 2018
Last update
Jun 8, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03412578
Lead sponsor
Mansoura University Children Hospital
Responsible party
Nehad Nasef (Associate Professor, Mansoura University Children Hospital) — Principal investigator
First posted
Jan 26, 2018
Start date
Sep 2014
Primary completion
Dec 2018
Completion
Dec 2018
Last update
Jun 8, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion